Chemoinformaics analysis of beta-sitosterol-beta-d-glucoside
| Molecular Weight | 576.859 | nRot | 9 |
| Heavy Atom Molecular Weight | 516.379 | nRig | 26 |
| Exact Molecular Weight | 576.439 | nRing | 5 |
| Solubility: LogS | -4.991 | nHRing | 1 |
| Solubility: LogP | 7.081 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 101 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 60 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 35 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 103.27 |
| nHD | 4 | BPOL | 63.6644 |
| QED | 0.257 |
| Synth | 4.99 |
| Natural Product Likeliness | 2.689 |
| NR-PPAR-gamma | 0.028 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.989 |
| Pgp-sub | 0.158 |
| HIA | 0.015 |
| CACO-2 | -4.757 |
| MDCK | 0.0000111 |
| BBB | 0.009 |
| PPB | 0.909463 |
| VDSS | 1.056 |
| FU | 0.0158382 |
| CYP1A2-inh | 0.019 |
| CYP1A2-sub | 0.324 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.856 |
| CYP2c9-inh | 0.126 |
| CYP2c9-sub | 0.042 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.058 |
| CYP3a4-inh | 0.341 |
| CYP3a4-sub | 0.44 |
| CL | 3.038 |
| T12 | 0.115 |
| hERG | 0.548 |
| Ames | 0.013 |
| ROA | 0.008 |
| SkinSen | 0.843 |
| Carcinogencity | 0.069 |
| EI | 0.059 |
| Respiratory | 0.894 |
| NR-Aromatase | 0.407 |
| Antiviral | No |
| Prediction | 0.602637 |